A study, using a global gene expression analysis approach, identified chemokine (C-C motif) ligand 2 (CCL2) as the transcript most effected by silencing FXYD5 in MDA-MB-231 breast cancer cells (Nam et al., 2006). This evidence concerns the gene FXYD5 and breast cancer.